These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 8733038

  • 1. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [Abstract] [Full Text] [Related]

  • 2. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 3. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G, Giustina A, Cravarezza P, Caldonazzo A, Agabiti-Rosei E, Giustina G.
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 5. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO, Coll JR, Tran ZV, Schrier RW.
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [Abstract] [Full Text] [Related]

  • 6. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
    [Abstract] [Full Text] [Related]

  • 7. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 8. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 9. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S, Serradimigni A.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [Abstract] [Full Text] [Related]

  • 10. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG, Kramer HJ.
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [Abstract] [Full Text] [Related]

  • 11. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Poulsen PL, Mogensen CE.
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ, Meany TB, Johnston GD, Kondowe G, Grimmer SF, Breckenridge AM.
    J Cardiovasc Pharmacol; 1987 Feb; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [Abstract] [Full Text] [Related]

  • 13. High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus.
    Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE.
    Kidney Int Suppl; 1997 Dec; 63():S15-8. PubMed ID: 9407413
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 15. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212
    [Abstract] [Full Text] [Related]

  • 16. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 17. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.
    Am J Hypertens; 1995 Aug 15; 8(8):808-14. PubMed ID: 7576397
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy.
    Giustina A, Ianniello P, Bossoni S, Comini MT, Desenzani P, Gazzoli N, Romanelli G.
    Clin Ther; 1994 Aug 15; 16(2):191-9. PubMed ID: 8062315
    [Abstract] [Full Text] [Related]

  • 19. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM, RENAAL Study Group.
    Arch Intern Med; 2003 Jul 14; 163(13):1555-65. PubMed ID: 12860578
    [Abstract] [Full Text] [Related]

  • 20. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R, Puig JG, Rodríguez-Pérez JC, Garrido J, Redon J, TRAVEND Study Group.
    J Hum Hypertens; 2001 Dec 14; 15(12):849-56. PubMed ID: 11773987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.